Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 25337750

Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2014 Oct 23
First author
Loupakis F

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2014 Dec;11(12):684. doi: 10.1038/nrclinonc.2014.194.
    note
    Source null
    related pmid
    25384949
    relationship
    Comment in
  2. citation
    N Engl J Med. 2015 Jan 15;372(3):291-2. doi: 10.1056/NEJMc1413996.
    note
    Source null
    related pmid
    25587960
    relationship
    Comment in
  3. citation
    N Engl J Med. 2015 Jan 15;372(3):290-1. doi: 10.1056/NEJMc1413996.
    note
    Source null
    related pmid
    25587961
    relationship
    Comment in
  4. citation
    N Engl J Med. 2015 Jan 15;372(3):291. doi: 10.1056/NEJMc1413996.
    note
    Source null
    related pmid
    25587962
    relationship
    Comment in

Authors and identifiers

  1. name
    Loupakis F
    type
    Author
  2. name
    Cremolini C
    type
    Author
  3. name
    Masi G
    type
    Author
  4. name
    Lonardi S
    type
    Author
  5. name
    Zagonel V
    type
    Author
  6. name
    Salvatore L
    type
    Author
  7. name
    Cortesi E
    type
    Author
  8. name
    Tomasello G
    type
    Author
  9. name
    Ronzoni M
    type
    Author
  10. name
    Spadi R
    type
    Author
  11. name
    Zaniboni A
    type
    Author
  12. name
    Tonini G
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Loupakis F
    type
    Author
  2. name
    Cremolini C
    type
    Author
  3. name
    Masi G
    type
    Author
  4. name
    Lonardi S
    type
    Author
  5. name
    Zagonel V
    type
    Author
  6. name
    Salvatore L
    type
    Author
  7. name
    Cortesi E
    type
    Author
  8. name
    Tomasello G
    type
    Author
  9. name
    Ronzoni M
    type
    Author
  10. name
    Spadi R
    type
    Author
  11. name
    Zaniboni A
    type
    Author
  12. name
    Tonini G
    type
    Author
bibliography ids
  1. nci-bib-0b9a64e9f1d4f29f7d746c9a
book metadata
content sha256
bc46d123aa91d83819780d59766990633a044dcf12d77c2c0584a9a271b39638
document type
citation
dois
  1. 10.1056/NEJMoa1403108
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:25337750
immutable id
pubmed:25337750@bc46d123aa91d83819780d59766990633a044dcf12d77c2c0584a9a271b39638
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
17
name
The New England journal of medicine
nlm unique id
0255562
pages
1609-18
volume
371
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2014 Dec;11(12):684. doi: 10.1038/nrclinonc.2014.194.
    note
    Source null
    related pmid
    25384949
    relationship
    Comment in
  2. citation
    N Engl J Med. 2015 Jan 15;372(3):291-2. doi: 10.1056/NEJMc1413996.
    note
    Source null
    related pmid
    25587960
    relationship
    Comment in
  3. citation
    N Engl J Med. 2015 Jan 15;372(3):290-1. doi: 10.1056/NEJMc1413996.
    note
    Source null
    related pmid
    25587961
    relationship
    Comment in
  4. citation
    N Engl J Med. 2015 Jan 15;372(3):291. doi: 10.1056/NEJMc1413996.
    note
    Source null
    related pmid
    25587962
    relationship
    Comment in
outcomes validated
false
pmid
25337750
provenance
batch id
863b068fe5a07222af6a
provider
NCBI PubMed ESummary
record sha256
7d658c854b0979a9adb628e84330b3bb5b25fece44432a02b3f17e2d9e19210d
response sha256
80b1cc99e93fcfceb3e1b12ea433c615b032a2db13a615db7a6e9382c17c5034
retrieved at
2026-09-09T23:47:07.648963+00:00
publication date
display
2014 Oct 23
precision
day
year
2014
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/25337750/
title
Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer.

Preserved source evidence · Independent clinical review pending · Not medical advice